Kenvue faces challenges with declining sales, cash flow risks, and high leverage. Read here for more analysis on KVUE stock.

Two years ago, when Johnson & Johnson announced it was spinning off its consumer brands including Tylenol, Band-Aid, Motrin, ...

Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...

Kenvue stock surged Monday after the company — known for brands like Tylenol — announced sweeping changes, including naming a ...

The consumer health company also disclosed its CEO’s departure, following its CFO replacement earlier this year, and appointed an interim chief executive. Preliminary second-quarter 2025 results show ...

Many global corporations will gird for costly and time-consuming battles, they said, even as some activist investors may be willing to compromise ... Enterprise and U.S. consumer healthcare company ...

CEO and board member Thibaut Mongon has stepped down, it said on Monday and named company director Kirk Perry as interim chief executive. The company, which was spun off from Johnson & Johnson ...

Starboard has been one of the industry's busiest activist investors, pushing for changes at several companies in the last one year, including Band-Aid maker Kenvue, drugmaker Pfizer and design ...

Kenvue's CEO and board member Thibaut Mongon has stepped down, it said on Monday, in the second big executive change at the ...

Investors said many activists remained on the sidelines in the second quarter, worried about how U.S. President Donald ...